AETHLON MEDICAL INC (AEMD) earnings date, results and what the price requires
Nasdaq · SEC CIK 0000882291 · SEC filings checked Oct 16, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 13, 2026 | — | $-1.5M | $-4.02 | Filing |
| Mar 31, 2026 | Jun 10, 2026 | — | $-1.9M | $38.00 | Filing |
| Dec 31, 2025 | Feb 12, 2026 | — | $-2.0M | $-2.45 | Filing |
| Sep 30, 2025 | Nov 12, 2025 | — | $-1.5M | $-3.74 | Filing |
| Jun 30, 2025 | Aug 13, 2025 | — | $-1.8M | $-42.42 | Filing |
| Mar 31, 2025 | Jun 27, 2025 | — | $-6.3M | $-56.85 | Filing |
| Dec 31, 2024 | Feb 12, 2025 | — | $-1.8M | $-10.05 | Filing |
| Sep 30, 2024 | Nov 13, 2024 | — | $-2.8M | $-16.11 | Filing |
What would AETHLON MEDICAL INC have to report for its valuation to change?
At $5.15, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about -56.4% a year, to $0.44. On that path the next quarter needs diluted EPS near $-1.63, against $-3.74 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | -56.4% | -56.4% |
| EPS needed in final year | $0.44 | $0.44 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. AEMD goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.